Amarin Corp PLC Q4 2018 Institutional Investor Sentiment Better Than Expected

Amarin Corporation plc (NASDAQ:AMRN) Logo

Sentiment for Amarin Corp PLC (NASDAQ:AMRN)

Amarin Corp PLC (NASDAQ:AMRN) institutional sentiment increased to 1.65 in 2018 Q4. Its up 0.02, from 1.63 in 2018Q3. The ratio has increased, as 107 investment professionals increased or started new holdings, while 65 cut down and sold their equity positions in Amarin Corp PLC. The investment professionals in our partner’s database reported: 139.69 million shares, up from 126.12 million shares in 2018Q3. Also, the number of investment professionals holding Amarin Corp PLC in their top 10 holdings increased from 7 to 10 for an increase of 3. Sold All: 18 Reduced: 47 Increased: 41 New Position: 66.

Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company has market cap of $5.76 billion. The companyÂ’s lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It currently has negative earnings. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels.

The stock decreased 0.31% or $0.05 during the last trading session, reaching $17.42. About 2.23 million shares traded. Amarin Corporation plc (NASDAQ:AMRN) has risen 537.69% since May 8, 2018 and is uptrending. It has outperformed by 533.32% the S&P500.

Analysts await Amarin Corporation plc (NASDAQ:AMRN) to report earnings on August, 7. They expect $-0.06 earnings per share, up 50.00 % or $0.06 from last year’s $-0.12 per share. After $-0.07 actual earnings per share reported by Amarin Corporation plc for the previous quarter, Wall Street now forecasts -14.29 % EPS growth.

Oracle Investment Management Inc holds 21.96% of its portfolio in Amarin Corporation plc for 5.20 million shares. Apis Capital Advisors Llc owns 1.16 million shares or 21.2% of their US portfolio. Moreover, Consonance Capital Management Lp has 9.46% invested in the company for 9.45 million shares. The Massachusetts-based Opaleye Management Inc. has invested 6.35% in the stock. Baker Bros. Advisors Lp, a New York-based fund reported 42.59 million shares.

Since January 1, 0001, it had 0 insider purchases, and 15 insider sales for $40.01 million activity.

Amarin Corporation plc (NASDAQ:AMRN) Ratings Coverage

Ratings analysis reveals 100% of Amarin’s analysts are positive. Out of 4 Wall Street analysts rating Amarin, 4 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $27 while the high is $51. The stock’s average target of $35.75 is 105.22% above today’s ($17.42) share price. AMRN was included in 10 notes of analysts from February 22, 2019. Stifel Nicolaus initiated the shares of AMRN in report on Thursday, March 21 with “Buy” rating. H.C. Wainwright maintained Amarin Corporation plc (NASDAQ:AMRN) rating on Tuesday, March 19. H.C. Wainwright has “Buy” rating and $51 target. Cantor Fitzgerald maintained the stock with “Buy” rating in Friday, February 22 report. The stock has “Buy” rating by Cantor Fitzgerald on Friday, March 15. Cantor Fitzgerald maintained the stock with “Buy” rating in Friday, March 22 report. The firm earned “Buy” rating on Thursday, February 28 by H.C. Wainwright. Jefferies maintained it with “Buy” rating and $30 target in Wednesday, February 27 report. The stock of Amarin Corporation plc (NASDAQ:AMRN) earned “Buy” rating by Cantor Fitzgerald on Friday, March 8.

More notable recent Amarin Corporation plc (NASDAQ:AMRN) news were published by: Seekingalpha.com which released: “Amarin Q1 2019 Earnings Preview – Seeking Alpha” on April 30, 2019, also Seekingalpha.com with their article: “Financial Exchange Stock Talk: Bhavneesh Sharma On Amarin – Seeking Alpha” published on January 30, 2019, Nasdaq.com published: “Why Amarin’s Stock Sank on Strong First-Quarter Results – Nasdaq” on May 02, 2019. More interesting news about Amarin Corporation plc (NASDAQ:AMRN) were released by: Nasdaq.com and their article: “Health Care Sector Update for 03/05/2019: AMRN,ACB,ACB.TO,ADMS – Nasdaq” published on March 05, 2019 as well as Seekingalpha.com‘s news article titled: “Amarin misses by $0.02, beats on revenue – Seeking Alpha” with publication date: February 27, 2019.

Amarin Corporation plc (NASDAQ:AMRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.